SA22 Tepotinib Versus Chemotherapy in Met Exon 14 (METex14) Skipping Non-Small Cell Lung Cancer (NSCLC): Real-World Evidence (RWE) and Matching-Adjusted Indirect Comparison (MAIC) to Explore the Impact of Subsequent Therapy

Autor: Wheat, H., Hatswell, A., Christopoulos, P., Ekman, S., Guisier, F., Hook, E., Vioix, H.
Zdroj: In Value in Health December 2023 26(12) Supplement:S545-S545
Databáze: ScienceDirect
Externí odkaz: